Challenges with 177 Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice
Journal of Nuclear Medicine · 19.09.2024 · jnumed.124.268023
DOI: 10.2967/jnumed.124.268023 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 19.09.2024. Verfasst von Hossein Jadvar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine and Molecular Imaging Center, Department of Radiology, Keck School of Medicine, University of Southern California, Los A…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
The U.S. Food and Drug Administration and the European Medicines Agency approved the first prostate-specific membrane antigen (PSMA)–targeted radiopharmaceutical therapy (RPT), 177Lu-PSMA-617 (177Lu-vipivotide tetraxetan [Pluvicto; Novartis/AAA]), for patients with metastatic castration-resistant
Autor:innen und Institutionen
- Division of Nuclear Medicine and Molecular Imaging Center, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California; jadvar@med.usc.edu.
- Division of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, Washington.
- Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
- Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.
Zitieren
APA
Jadvar, H., Iravani, A., Bodei, L., & Calais, J. (2024). Challenges with 177 Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice. Journal of Nuclear Medicine, jnumed.124.268023. https://doi.org/10.2967/jnumed.124.268023
Vancouver
Jadvar H, Iravani A, Bodei L, Calais J. Challenges with 177 Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice. Journal of Nuclear Medicine. 2024:jnumed.124.268023. doi:10.2967/jnumed.124.268023
BibTeX
@article{Jadvar2024,
author = {Jadvar, Hossein and Iravani, Amir and Bodei, Lisa and Calais, Jeremie},
title = {Challenges with 177 Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice},
journal = {Journal of Nuclear Medicine},
year = {2024},
pages = {jnumed.124.268023},
doi = {10.2967/jnumed.124.268023}
}
EUVIMED